Skip to content

Incidence of anemia in hospitalized patients with advanced malignant tumors receiving third-line or above antitumor therapy in Beijing area: A multicenter cross-sectional study

Incidence of anemia in hospitalized patients with advanced malignant tumors receiving third-line or above antitumor therapy in Beijing area: A multicenter cross-sectional study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300073416
Enrollment
Unknown
Registered
2023-07-10
Start date
2023-07-20
Completion date
Unknown
Last updated
2023-07-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cancer related anemia(CRA)

Interventions

Cancer related anemia:None

Sponsors

Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: (1) Patients diagnosed by cytology/histopathology as lung cancer, breast cancer, lymphoma, esophageal cancer, stomach cancer, colorectal cancer, ovarian cancer, cervical cancer, endometrial cancer; (2) =18 years old, gender is not limited; (3) In line with the CRA Western medicine diagnostic criteria of the Chinese Society of Clinical Oncology (CSCO) Clinical Practice Guidelines for Tumor-related Anemia (2022 edition) issued by the Chinese Society of Clinical Oncology: adult male HGB < 120g/L; Non-pregnant adult female HGB < 110g/L; (4) Tumor patients who have received third-line treatment or above anti-tumor treatment and have peripheral blood routine results; (5) The general situation and clinical data are complete.

Exclusion criteria

Exclusion criteria: (1) suffering from two or more primary malignant tumors; (2) Anemia caused by bone marrow metastasis or combined with hematological diseases.

Design outcomes

Primary

MeasureTime frame
Anemia incidence rate;Hemoglobin level;

Secondary

MeasureTime frame
Anti anemia treatment;Distribution of Traditional Chinese Medicine Syndrome Elements;

Countries

China

Contacts

Public ContactLi Hou

Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine

houli1203@126.com+86 84013145

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026